For Medical Affairs
From Programme Data to Longitudinal Medical Intelligence.
PACE Align reveals how patients actually use and continue therapy over time, turning longitudinal programme signals into structured medical intelligence on persistence, treatment rhythm, barriers, interventions, patient cohorts and evidence gaps.
Current challenge
- Retrospective activity reports leave longitudinal treatment questions unanswered.
- Limited visibility into treatment duration, persistence, interruptions and treatment-rhythm deviation over time.
- Barrier and discontinuation reasons may be inconsistently structured or incomplete.
- Intervention-to-outcome relationships can be difficult to evaluate across fragmented programme records.
- Cohort differences by age group, gender, indication, specialty, care setting or region may be hard to investigate.
- Evidence gaps are difficult to identify without consistent longitudinal programme data.
Six medical intelligence pillars
- 1
Longitudinal treatment patterns
Review treatment initiation, duration, persistence, interruption and discontinuation over time.
- 2
Treatment-rhythm intelligence
Compare the recorded expected schedule with observed intervals. Separate delayed dose, missed dose, extended interval, clinician-directed change and unknown reason.
- 3
Barrier intelligence
Understand recurring reported barriers, unresolved needs and reasons for interruption/discontinuation.
- 4
Cohort insights
Explore aggregate patterns by age group, gender, indication, specialty, care setting and region where data are lawfully collected and sufficiently aggregated.
- 5
Intervention outcomes
Review recorded support, documented resolution and subsequent treatment status without claiming causality.
- 6
Evidence-gap identification
Use structured programme data to identify questions that warrant deeper scientific investigation, appropriate education or formal RWE study design.
Structured programme data that supports your evidence questions.
PACE structures programme data to support medical insight, evidence-gap identification and defined RWE analyses. A specific research question, appropriate methods and relevant review are still required. PACE does not replace HEOR, formal RWE studies, clinical research or regulatory review.
Bring one programme challenge. See how PACE addresses it.
Explore longitudinal treatment patterns, treatment rhythm, barriers and cohorts for one programme, and discuss the evidence questions that matter to your team.
Pilot proof-of-value measures
- Time from risk signal to action
- Overdue follow-ups
- Ageing unresolved cases
- Documented resolution
- Persistence / discontinuation
- Handover completeness